206 related articles for article (PubMed ID: 32852648)
21. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
[TBL] [Abstract][Full Text] [Related]
22. High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis.
Lee KK; Lee JY; Nam JM; Kim CB; Park KR
Brachytherapy; 2015; 14(4):449-57. PubMed ID: 25906951
[TBL] [Abstract][Full Text] [Related]
23. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
24. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
25. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
27. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
[TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis of local recurrence pattern by computed tomography image-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer in a single Japanese institution.
Umezawa R; Tokunaga H; Yamamoto T; Shigeta S; Takahashi N; Takeda K; Suzuki Y; Kishida K; Ito K; Kadoya N; Shimada M; Jingu K
Brachytherapy; 2023; 22(4):477-486. PubMed ID: 37208225
[TBL] [Abstract][Full Text] [Related]
29. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
[TBL] [Abstract][Full Text] [Related]
30. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
[TBL] [Abstract][Full Text] [Related]
31. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
[TBL] [Abstract][Full Text] [Related]
32. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
[TBL] [Abstract][Full Text] [Related]
33. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
34. Preliminary results of conformal computed tomography (CT)-based intracavitary brachytherapy (ICBT) for locally advanced cervical cancer: a single institution's experience.
Tharavichitkul E; Mayurasakorn S; Lorvidhaya V; Sukthomya V; Wanwilairat S; Lookaew S; Pukanhaphan N; Chitapanarux I; Galalae R
J Radiat Res; 2011; 52(5):634-40. PubMed ID: 21952319
[TBL] [Abstract][Full Text] [Related]
35. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
[TBL] [Abstract][Full Text] [Related]
36. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
[TBL] [Abstract][Full Text] [Related]
37. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer.
Christensen EN; Yu HZ; Klopp AH; Tsai JC; Lawyer AA; Court LE; Eifel PJ
Brachytherapy; 2014; 13(3):240-9. PubMed ID: 24188993
[TBL] [Abstract][Full Text] [Related]
38. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract][Full Text] [Related]
39. Dynamic rotating-shield brachytherapy.
Liu Y; Flynn RT; Kim Y; Yang W; Wu X
Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
[TBL] [Abstract][Full Text] [Related]
40. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
